Evidence map›Paper›PMID 23073755›Full record

ArticleIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2012

Survey of inflammatory bowel diseases in India.

Govind K Makharia, Balakrishnan S Ramakrishna, Philip Abraham, Gourdas Choudhuri, Sri Prakash Misra, Vineet Ahuja, Shobna J Bhatia, Deepak K Bhasin, Sunil Dadhich, Gopal K Dhali and 14 more

Abstract read
PubMed Publisher
In one paragraph

Article in Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Perianal fistulizing Crohn's disease: Clinical practice update from Colitis and Crohn's Foundation (India).Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Guideline
  2. Indian Society of Gastroenterology consensus on ulcerative colitis.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2012
    Guideline
  3. Trends in the use of biologic agents and their persistence rates in inflammatory bowel disease in India.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Article
  4. Economic burden borne by patients due to diagnostic delays in inflammatory bowel disease: Insights from a survey of newly diagnosed patients.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2026
    Observational
  5. Article
  6. Inflammatory bowel disease in south Asia: a scoping review.The lancet. Gastroenterology & hepatology · 2025
    Article
  7. Article
  8. Article
  9. Spectrum and trend of pediatric inflammatory bowel disease: A two-decade experience from northern India.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn's disease: A cohort study from northern India.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2023
    Article
  14. A prospective study of inflammatory bowel disease phenotypes in extremes of age and comparison with adults.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices.JGH open : an open access journal of gastroenterology and hepatology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 15 institutions in 2 countries.

Govind K MakhariaAll India Institute of Medical Sciences, New Delhi, India.
Balakrishnan S Ramakrishna
Philip Abraham
Gourdas Choudhuri
Sri Prakash Misra
Vineet Ahuja
Shobna J Bhatia
Deepak K Bhasin
Sunil Dadhich
Gopal K Dhali
Devendra C Desai
Uday C Ghoshal
B D Goswami
Sanjeev K Issar
Ajay K Jain
Venkataraman Jayanthi
Goundappa Loganathan
C Ganesh Pai
Amarender S Puri
Surinder S Rana
Gautam Ray
Shivaram P Singh
Ajit Sood
Indian Society of Gastroenterology Task Force on Inflammatory Bowel Disease
Sanjay Gandhi Post Graduate Institute of Medical Sciences · INAll India Institute of Medical Sciences · INChristian Medical College, Vellore · INGauhati Medical College and Hospital · INGovind Ballabh Pant Hospital · INSriram Chandra Bhanja Medical College Hospital · INStanley Medical College · INDayanand Medical College & Hospital · INIndian Institute of Technology Bhilai · INInstitute of Post Graduate Medical Education and Research · INMotilal Nehru Medical College · INP. D. Hinduja Hospital and Medical Research Centre · INPost Graduate Institute of Medical Education and Research · INSir Ganga Ram Hospital · PKVinayaka Missions Medical College and Hospitals · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInflammatory bowel disease (IBD), both ulcerative colitis (UC) and Crohn's disease (CD), once thought to be uncommon, is now seen commonly in India. The Indian Society of Gastroenterology (ISG) Task Force on IBD decided to collate data on the clinical spectrum of IBD currently prevailing in India.

methodsAn open call to members of ISG was given through publication of a proforma questionnaire in the Indian Journal of Gastroenterology and the web portal of ISG. The proforma contained questions related with demographic features, family history, risk factors, clinical manifestations and characteristics, course of disease, and pattern of treatment of IBD.

resultsOf 1,255 filled questionnaires received, 96 were rejected and 1,159 (92.3 %) were analyzed. This comprised data on 745 (64.3 %) patients with UC, 409 (35.3 %) with CD, and 5 with indeterminate colitis. The median duration of illness was longer in patients with CD (48 months) compared to those with UC (24 months) (p = 0.002). More than one half of patients (UC 51.6 %, CD 56.9 %) had one or more extraintestinal symptoms. A definite family history of IBD was present in 2.9 % (UC 2.3 % and CD 4.6 %; p = 0.12). The extent of disease in UC was pancolitis 42.8 %, left-sided colitis 38.8 %, and proctitis alone in 18.3 %. The extent of disease involvement in CD was both small and large intestine in 39.6 %, colon alone in 31.4 % and small intestine alone in 28.9 %. Stricturing and fistulizing disease were noted in 18.8 % and 4.4 % of patients with CD respectively. Chronic continuous and intermittent disease course were present in 35.5 % and 47.2 % of UC patients respectively, and in 23.1 % and 68.8 % of CD patients. Four percent of patients with UC had undergone colectomy, while 15.2 % of patients with CD underwent surgical intervention.

conclusionsThe present survey provides a reasonable picture of the demographic features and clinical manifestations of Indian patients with IBD, their risk factors, course of disease, and the treatment given to them.

Indexed as

AdultConstriction, PathologicFemaleHumansIndiaInflammatory Bowel DiseasesIntestinal FistulaIntestinesMaleSeverity of Illness Index

Identifiers

PMID23073755
OpenAlexW2051653937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.